Snisarenko John 4
4 · Oyster Point Pharma, Inc. · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Snisarenko John
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-01-29+50,500→ 50,500 totalExercise: $18.77Exp: 2031-01-28→ Common Stock (50,500 underlying) - Award
Common Stock
2021-01-29+11,222→ 18,222 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]25% of the RSUs vest on January 29, 2022 and the remainder vest annually thereafter on the same day of the month as the grant date over the following 3 years, subject to the Reporting Person's continuous service to the Issuer through each such date.
- [F3]Options granted on January 29, 2021 under the Oyster Point Pharma, Inc. 2019 Equity Incentive Plan. 25% of the options shall vest and become exercisable on January 29, 2022 and one thirty-sixth (1/36) of the remaining options shall vest monthly thereafter on the same day of the month (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service to the Issuer through each such date.